Sunitinib Malate
Sunitinib is an indolinone-based tyrosine kinase inhibitor. It blocks the tyrosine kinase activities of VEGFR2, PDGFRβ (IC50: 80/2 nM), and c-kit.
| Catalog Number | T0374 |
| Alternative Name(s) | Sutent , SU 11248 (Malate) , SU 11248 , Sunitinib |
| Research Area | Autophagy|||Angiogenesis|||Apoptosis|||Cell Cycle/Checkpoint|||Tyrosine Kinase/Adaptors |
| Molecular Formula | C26H33FN4O7 |
| CAS# | 341031-54-7 |
| Purity | 98.09% |
| SMILES | O[C@@H](CC(O)=O)C(O)=O.CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C |
| Size | 200 mg |
| Supplier Page | https://www.targetmol.com/compound/Sunitinib Malate |
| Additional Information | https://www.targetmol.com/datasheet/T0374 |